Latest Organofluorides Stories
DUBLIN, Dec. 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the Company has received a complete response letter from the U.S.
Study Seeks to Confirm a High Response Rate among Cancer Patients with MET and Axl Genetic Alterations SAN DIEGO, Dec. 23, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc.
The Firm is currently representing numerous men and boys in Risperdal lawsuits that also allege the drug caused gynecomastia, a condition marked by the excessive breast growth in male patients.
The Firm is representing numerous men and boys in Risperdal lawsuits, all of whom allegedly developed gynecomastia (male breast growth) due to an elevation of prolactin caused by Risperdal.
Publication of the study comes amid numerous Risperdal lawsuit filings that allege the medication caused gynecomastia in men and boys. New York, New York (PRWEB)
-- Novel irreversible pan-erbB inhibitor is active against patient-derived GBM xenografts overexpressing EGFR, including the disease-driving EGFRvIII mutation MENLO PARK, Calif., Dec.
BOTHELL, Wash. and VANCOUVER, British Columbia, Dec. 16, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc.
RnRMarketResearch.com adds “Ethylene Tetrafluoroethylene (ETFE) Market by Type (Powder, Granule & others), by Technology (Extrusion, Injection & others), and by Application (Film &
The Firm is currently representing men and young boys in Risperdal lawsuits that allege male gynecomastia allegedly resulting from their use of the antipsychotic medication. New
The Firm is representing numerous men and boys in Risperdal gynecomastia claims that also raise questions about the manner in which the atypical antipsychotic drug was marketed. New
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.